SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-015801
Filing Date
2022-04-26
Accepted
2022-04-26 06:05:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20002876x2_defa14a.htm DEFA14A 6712
2 ny20002876x2_nc01.jpg GRAPHIC 384825
3 ny20002876x2_nc02.jpg GRAPHIC 256526
  Complete submission text file 0001140361-22-015801.txt   887254
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36500 | Film No.: 22851638
SIC: 2834 Pharmaceutical Preparations